CBFB and leukemia: Our lab previously showed that HDAC1 is required for active transcription of RUNX1 target genes in a mouse model of CBFβ::SMMHC (CM) driven AML, making leukemia cells particularly sensitive to the HDAC1 inhibitor, entinostat [9].